Morphiex Biotherapeutics (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Morphiex Biotherapeutics

Founded 2018

Boston, United States 2-10 employees Biotechnology, Health Care +1

Morphiex Biotherapeutics is a biotechnology startup founded in 2018 that is focused on leveraging the potential of the immune system to combat cancer. The company's primary drug candidate, MBT-001, is a dual-functioning #CD47 immune checkpoint inhibitor, designed to block the "don't eat me" and thrombospondin-1 (TSP-1) pathways of #CD47. This mechanism enables T cells, Natural Killer cells, Neutrophils, and Macrophages to directly eliminate tumor cells. Notably, MBT-001 was developed at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) and is exclusively licensed to Morphiex for cancer treatment as a monotherapy or combinational therapy. The company has also entered into a cooperative research and development agreement (CRADA) with the NIH/NCI to expedite the development of MBT-001. Morphiex operates within the Biotechnology, Health Care, and Pharmaceutical sectors. As of now, specific details regarding the company's headquarters, last investment, and investors remain undisclosed.

FAQ About Morphiex Biotherapeutics

Morphiex is harnessing the power of the immune system to fight cancer by developing the only dual-functioning #CD47 immune checkpoint inhibitor. Our lead drug candidate, MBT-001, blocks both "don't eat me" and thrombospondin-1 (TSP-1) pathways of #CD47. This enables direct tumor cell killing mediat...

Morphiex Biotherapeutics was founded in 2018.

Morphiex Biotherapeutics is headquartered in Boston, United States.

Morphiex Biotherapeutics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.

Morphiex Biotherapeutics has approximately 2-10 employees.

Top alternatives and competitors to Morphiex Biotherapeutics include Trillium Therapeutics Inc., 宜明昂科生物医药技术(上海)有限公司, Shuttle Pharmaceuticals, Inc., Biothera Pharmaceuticals, Inc., UbiVac. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Morphiex Biotherapeutics and Trillium Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Morphiex Biotherapeutics

General Information

Track Morphiex Biotherapeutics

Discover More

About Morphiex Biotherapeutics

Morphiex Biotherapeutics Alternatives & Competitors

FAQ About Morphiex Biotherapeutics

Don't just browse. Track.